Cargando…
Use of botulinum toxin for movement disorders
The term movement disorders encompasses all disorders hypokinetic and hyperkinetic, which were previously known as extrapyramidal syndromes. With the definition of movement disorders and their diagnostic criteria and classifications, new studies for therapeutics could be performed. New drugs were la...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586173/ https://www.ncbi.nlm.nih.gov/pubmed/31258617 http://dx.doi.org/10.7573/dic.212586 |
_version_ | 1783428853800108032 |
---|---|
author | Camargo, Carlos Henrique Ferreira Teive, Hélio Afonso Ghizoni |
author_facet | Camargo, Carlos Henrique Ferreira Teive, Hélio Afonso Ghizoni |
author_sort | Camargo, Carlos Henrique Ferreira |
collection | PubMed |
description | The term movement disorders encompasses all disorders hypokinetic and hyperkinetic, which were previously known as extrapyramidal syndromes. With the definition of movement disorders and their diagnostic criteria and classifications, new studies for therapeutics could be performed. New drugs were launched, functional neurosurgery was developed, and the introduction of botulinum toxin (BoNT) for hyperkinesias was introduced. BoNT is an important therapy for dystonia, tics, myoclonus, and tremors. The aim of this review is to present the new and well-established uses of BoNT for movement disorders. |
format | Online Article Text |
id | pubmed-6586173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioExcel Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-65861732019-06-28 Use of botulinum toxin for movement disorders Camargo, Carlos Henrique Ferreira Teive, Hélio Afonso Ghizoni Drugs Context Review The term movement disorders encompasses all disorders hypokinetic and hyperkinetic, which were previously known as extrapyramidal syndromes. With the definition of movement disorders and their diagnostic criteria and classifications, new studies for therapeutics could be performed. New drugs were launched, functional neurosurgery was developed, and the introduction of botulinum toxin (BoNT) for hyperkinesias was introduced. BoNT is an important therapy for dystonia, tics, myoclonus, and tremors. The aim of this review is to present the new and well-established uses of BoNT for movement disorders. BioExcel Publishing Ltd 2019-06-18 /pmc/articles/PMC6586173/ /pubmed/31258617 http://dx.doi.org/10.7573/dic.212586 Text en Copyright © 2019 Camargo CHF, Teive HAG. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission. |
spellingShingle | Review Camargo, Carlos Henrique Ferreira Teive, Hélio Afonso Ghizoni Use of botulinum toxin for movement disorders |
title | Use of botulinum toxin for movement disorders |
title_full | Use of botulinum toxin for movement disorders |
title_fullStr | Use of botulinum toxin for movement disorders |
title_full_unstemmed | Use of botulinum toxin for movement disorders |
title_short | Use of botulinum toxin for movement disorders |
title_sort | use of botulinum toxin for movement disorders |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586173/ https://www.ncbi.nlm.nih.gov/pubmed/31258617 http://dx.doi.org/10.7573/dic.212586 |
work_keys_str_mv | AT camargocarloshenriqueferreira useofbotulinumtoxinformovementdisorders AT teivehelioafonsoghizoni useofbotulinumtoxinformovementdisorders |